Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data Challenge
- 1 November 2021
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 5 (5) , 51-54
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening MammogramsJAMA Network Open, 2020
- Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive diseaseLeukemia, 2020
- Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response RatesJournal of Oncology, 2019
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy responseNature Medicine, 2018
- Alternative models for sharing confidential biomedical dataNature Biotechnology, 2018
- The Immune Landscape of CancerImmunity, 2018
- The application of crowdsourcing approaches to cancer research: a systematic reviewCancer Medicine, 2017
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung CancerNew England Journal of Medicine, 2017
- Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial dataThe Lancet Oncology, 2017
- Crowdsourcing biomedical research: leveraging communities as innovation enginesNature Reviews Genetics, 2016